Interventional Cardiology: Current Challenges in Acute Myocardial Infarction
Funding
Conflicts of Interest
References
- Mach, F.; Baigent, C.; Catapano, A.L.; Koskinas, K.C.; Casula, M.; Badimon, L.; Chapman, M.J.; De Backer, G.G.; Delgado, V.; Ference, B.A.; et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur. Heart J. 2020, 41, 111–188. [Google Scholar] [CrossRef] [PubMed]
- Banach, M.; Penson, P.E.; Vrablik, M.; Bunc, M.; Dyrbus, K.; Fedacko, J.; Gaita, D.; Gierlotka, M.; Jarai, Z.; Magda, S.L.; et al. Optimal use of lipid-lowering therapy after acute coronary syndromes: A Position Paper endorsed by the International Lipid Expert Panel (ILEP). Pharmacol. Res. 2021, 166, 105499. [Google Scholar] [CrossRef]
- Ray, K.K.; Reeskamp, L.F.; Laufs, U.; Banach, M.; Mach, F.; Tokgozoglu, L.S.; Connolly, D.L.; Gerrits, A.J.; Stroes, E.S.G.; Masana, L.; et al. Combination lipid-lowering therapy as first-line strategy in very high-risk patients. Eur. Heart J. 2022, 43, 830–833. [Google Scholar] [CrossRef] [PubMed]
- Schäfer, A.; Sanchez Martinez, C.; Flierl, U.; Leitolf, H.; Tillmanns, J.; Bauersachs, J. Standardized secondary prevention in patients with ST-elevation myocardial infarction. Eur. J. Prevent Cardiol. 2020, 28, e35–e38. [Google Scholar] [CrossRef] [PubMed]
- Collet, J.P.; Thiele, H.; Barbato, E.; Barthelemy, O.; Bauersachs, J.; Bhatt, D.L.; Dendale, P.; Dorobantu, M.; Edvardsen, T.; Folliguet, T.; et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur. Heart J. 2020, 42, 1289–1367. [Google Scholar] [CrossRef] [PubMed]
- Collet, J.P.; Thiele, H.; Giannitsis, E.; Sibbing, D.; Barthelemy, O.; Bauersachs, J.; Bhatt, D.L.; Dendale, P.; Dorobantu, M.; Edvardsen, T.; et al. Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy. Eur. Heart J. 2021, 42, 2973–2985. [Google Scholar] [CrossRef]
- Schafer, A.; Bauersachs, J. P2Y12 inhibition in acute coronary syndromes treated with percutaneous intervention—Understanding the debate on Prasugrel or Ticagrelor. Pharmacol. Ther. 2021, 233, 108029. [Google Scholar] [CrossRef]
- Scholz, K.H.; Maier, S.K.G.; Maier, L.S.; Lengenfelder, B.; Jacobshagen, C.; Jung, J.; Fleischmann, C.; Werner, G.S.; Olbrich, H.G.; Ott, R.; et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: Results from the German prospective, multicentre FITT-STEMI trial. Eur. Heart J. 2018, 39, 1065–1074. [Google Scholar] [CrossRef] [Green Version]
- Thiele, H.; Akin, I.; Sandri, M.; Fuernau, G.; de Waha, S.; Meyer-Saraei, R.; Nordbeck, P.; Geisler, T.; Landmesser, U.; Skurk, C.; et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N. Engl. J. Med. 2017, 377, 2419–2432. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schafer, A.; Westenfeld, R.; Sieweke, J.T.; Zietzer, A.; Wiora, J.; Masiero, G.; Sanchez Martinez, C.; Tarantini, G.; Werner, N. Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated with Improved Mortality. Front. Cardiovasc. Med. 2021, 8, 678748. [Google Scholar] [CrossRef]
- Aurigemma, C.; Burzotta, F.; Chieffo, A.; Briguori, C.; Piva, T.; De Marco, F.; Di Biasi, M.; Pagnotta, P.; Casu, G.; Garbo, R.; et al. Clinical Impact of Revascularization Extent in Patients Undergoing Impella-Protected PCI Enrolled in a Nationwide Registry. JACC Cardiovasc. Interv. 2021, 14, 717–719. [Google Scholar] [CrossRef] [PubMed]
- Masiero, G.; Cardaioli, F.; Rodino, G.; Tarantini, G. When to Achieve Complete Revascularization in Infarct-Related Cardiogenic Shock. J. Clin. Med. 2022, 11, 3116. [Google Scholar] [CrossRef] [PubMed]
- Schäfer, A.; Werner, N.; Burkhoff, D.; Sieweke, J.-T.; Zietzer, A.; Masyuk, M.; Junker Udesen, N.L.; Westenfeld, R.; Moller, J.E. Influence of timing and predicted risk on mortality in Impella-treated infarct-related cardiogenic shock patients. Frontiers in Cardiovasc. Med. 2020, 7, 74. [Google Scholar] [CrossRef] [PubMed]
- O’Neill, W.W.; Grines, C.; Schreiber, T.; Moses, J.; Maini, B.; Dixon, S.R.; Ohman, E.M. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device. Am. Heart J. 2018, 202, 33–38. [Google Scholar] [CrossRef]
- Tongers, J.; Sieweke, J.T.; Kuhn, C.; Napp, L.C.; Flierl, U.; Rontgen, P.; Schmitto, J.D.; Sedding, D.G.; Haverich, A.; Bauersachs, J.; et al. Early Escalation of Mechanical Circulatory Support Stabilizes and Potentially Rescues Patients in Refractory Cardiogenic Shock. Circ. Heart Fail. 2020, 13, e005853. [Google Scholar] [CrossRef] [PubMed]
- Pappalardo, F.; Schulte, C.; Pieri, M.; Schrage, B.; Contri, R.; Soeffker, G.; Greco, T.; Lembo, R.; Mullerleile, K.; Colombo, A.; et al. Concomitant implantation of Impella(R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur. J. Heart Fail. 2017, 19, 404–412. [Google Scholar] [CrossRef]
- Junker Udesen, N.L.; Moller, J.E.; Lindholm, M.G.; Eiskjaer, H.; Schäfer, A.; Werner, N.; Holmvang, L.; Terkelsen, C.J.; Okkels Jensen, L.; Junker, A.; et al. Rationale and design of the Danish German cardiogenic shock trial—DanGer Shock trial. Am. Heart J. 2019, 214, 60–68. [Google Scholar] [CrossRef]
- Thiele, H.; Freund, A.; Gimenez, M.R.; de Waha-Thiele, S.; Akin, I.; Poss, J.; Feistritzer, H.J.; Fuernau, G.; Graf, T.; Nef, H.; et al. Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock—Design and rationale of the ECLS-SHOCK trial. Am. Heart J. 2021, 234, 1–11. [Google Scholar] [CrossRef]
- Banning, A.S.; Adriaenssens, T.; Berry, C.; Bogaerts, K.; Erglis, A.; Distelmaier, K.; Guagliumi, G.; Haine, S.; Kastrati, A.; Massberg, S.; et al. Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: Rationale and design of the randomised, multicentre, open-label EURO SHOCK trial. EuroIntervention 2021, 16, e1227–e1236. [Google Scholar] [CrossRef]
- Moller, J.E.; Kjaergaard, J.; Terkelsen, C.J.; Hassager, C. Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock. J. Clin. Med. 2022, 11, 2427. [Google Scholar] [CrossRef]
- Freund, A.; Desch, S.; Poess, J.; Sulimov, D.; Sandri, M.; Majunke, N.; Thiele, H. Extracorporeal membrane oxygenation in infarct-related cardiogenic shock. J. Clin. Med. 2022, 11, 1256. [Google Scholar] [CrossRef] [PubMed]
- Stone, G.W.; Selker, H.P.; Thiele, H.; Patel, M.R.; Udelson, J.E.; Ohman, E.M.; Maehara, A.; Eitel, I.; Granger, C.B.; Jenkins, P.L.; et al. Relationship Between Infarct Size and Outcomes Following Primary PCI: Patient-Level Analysis from 10 Randomized Trials. J. Am. Coll. Cardiol. 2016, 67, 1674–1683. [Google Scholar] [CrossRef] [PubMed]
- Hausenloy, D.J.; Yellon, D.M. Time to take myocardial reperfusion injury seriously. N. Engl J. Med. 2008, 359, 518–520. [Google Scholar] [CrossRef] [PubMed]
- Kloner, R.A. Does reperfusion injury exist in humans? J. Am. Coll. Cardiol. 1993, 21, 537–545. [Google Scholar] [CrossRef]
- Noc, M.; Laanmets, P.; Neskovic, A.N.; Petrovic, M.; Stanetic, B.; Aradi, D.; Kiss, R.G.; Ungi, I.; Merkely, B.; Hudec, M.; et al. A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction: The COOL AMI EU Pivotal Trial. EuroIntervention 2021, 17, 466–473. [Google Scholar] [CrossRef] [PubMed]
- El Farissi, M.; Good, R.; Engstrom, T.; Oldroyd, K.G.; Karamasis, G.V.; Vlaar, P.J.; Lonborg, J.T.; Teeuwen, K.; Keeble, T.R.; Mangion, K.; et al. Safety of Selective Intracoronary Hypothermia During Primary Percutaneous Coronary Intervention in Patients with Anterior STEMI. JACC Cardiovasc. Interv. 2021, 14, 2047–2055. [Google Scholar] [CrossRef]
- El Farissi, M.; Mast, T.P.; van de Kar, M.R.D.; Dillen, D.M.M.; Demandt, J.P.A.; Vervaat, F.E.; Eerdekens, R.; Dello, S.A.G.; Keulards, D.C.; Zelis, J.M.; et al. Hypothermia for Cardioprotection in Patients with St-Elevation Myocardial Infarction: Do Not Give It the Cold Shoulder Yet! J. Clin. Med. 2022, 11, 1082. [Google Scholar] [CrossRef] [PubMed]
- Kloner, R.A.; Creech, J.L.; Stone, G.W.; O’Neill, W.W.; Burkhoff, D.; Spears, J.R. Update on Cardioprotective Strategies for STEMI: Focus on Supersaturated Oxygen Delivery. JACC Basic Transl. Sci. 2021, 6, 1021–1033. [Google Scholar] [CrossRef] [PubMed]
- Stone, G.W.; Martin, J.L.; de Boer, M.J.; Margheri, M.; Bramucci, E.; Blankenship, J.C.; Metzger, D.C.; Gibbons, R.J.; Lindsay, B.S.; Weiner, B.H.; et al. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction. Circ. Cardiovasc. Interv. 2009, 2, 366–375. [Google Scholar] [CrossRef] [Green Version]
- Schäfer, A.; Akin, M.; Diekmann, J.; König, T. Intracoronary application of super-saturated oxygen to reduce infarct size following myocardial infarction. J. Clin. Med. 2022, 11, 1509. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Schäfer, A. Interventional Cardiology: Current Challenges in Acute Myocardial Infarction. J. Clin. Med. 2022, 11, 4504. https://doi.org/10.3390/jcm11154504
Schäfer A. Interventional Cardiology: Current Challenges in Acute Myocardial Infarction. Journal of Clinical Medicine. 2022; 11(15):4504. https://doi.org/10.3390/jcm11154504
Chicago/Turabian StyleSchäfer, Andreas. 2022. "Interventional Cardiology: Current Challenges in Acute Myocardial Infarction" Journal of Clinical Medicine 11, no. 15: 4504. https://doi.org/10.3390/jcm11154504